ES330013A1 - Un procedimiento para componer una preparacion farmaceutica. - Google Patents

Un procedimiento para componer una preparacion farmaceutica.

Info

Publication number
ES330013A1
ES330013A1 ES0330013A ES330013A ES330013A1 ES 330013 A1 ES330013 A1 ES 330013A1 ES 0330013 A ES0330013 A ES 0330013A ES 330013 A ES330013 A ES 330013A ES 330013 A1 ES330013 A1 ES 330013A1
Authority
ES
Spain
Prior art keywords
weight
adhesive composition
adhesive
coating
core material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0330013A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES330013A1 publication Critical patent/ES330013A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES0330013A 1965-08-09 1966-08-08 Un procedimiento para componer una preparacion farmaceutica. Expired ES330013A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US478437A US3365365A (en) 1965-08-09 1965-08-09 Repeat action pharmaceutical compositions in the form of discrete beadlets

Publications (1)

Publication Number Publication Date
ES330013A1 true ES330013A1 (es) 1967-06-16

Family

ID=23899930

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0330013A Expired ES330013A1 (es) 1965-08-09 1966-08-08 Un procedimiento para componer una preparacion farmaceutica.

Country Status (5)

Country Link
US (1) US3365365A (enFirst)
BE (1) BE685228A (enFirst)
BR (1) BR6681937D0 (enFirst)
ES (1) ES330013A1 (enFirst)
NL (1) NL6611190A (enFirst)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
WO1989004689A1 (en) * 1987-11-16 1989-06-01 Baxter International Inc. Glassy matrix for administration of beneficial agent
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
AU2001232020A1 (en) * 2000-02-09 2001-08-20 West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited Floating drug delivery composition
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
EP2726066B1 (en) 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosage forms of amphetamine for oral administration
ES2879892T3 (es) 2012-05-21 2021-11-23 Capsugel Belgium Nv Uso de una solución banda resistente a los ácidos para sellar cápsulas duras de dos piezas
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
IT201700048797A1 (it) * 2017-05-05 2018-11-05 Neilos S R L Sistema di rilascio controllato di ingredienti attivi a base di materiali polimerici e suo impiego in campo nutraceutico.
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043747A (en) * 1958-10-22 1962-07-10 Upjohn Co Tablets coated with carboxymethylcellulose shellac composition

Also Published As

Publication number Publication date
US3365365A (en) 1968-01-23
BE685228A (enFirst) 1967-02-08
NL6611190A (enFirst) 1967-02-10
BR6681937D0 (pt) 1973-10-25

Similar Documents

Publication Publication Date Title
ES330013A1 (es) Un procedimiento para componer una preparacion farmaceutica.
DE2336218C3 (de) Orale Arzneiform
US3080294A (en) Sustained release type of pharmaceutical vehicles
ES303909A1 (es) Un procedimiento para recubrir una composicion farmaceutica.
ATE66142T1 (de) Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung.
NO175186C (no) Fremgangsmåte for fremstilling av et osmotisk avgivende, oralt avleveringssystem inneholdende et moderat vannopplöselig, farmasöytisk akseptabelt salt av metoprolol
FI48318C (fi) Menetelmä terapeuttisesti aktiivista ainetta ja/tai bariumsulfaattia s isältävän kapselin tai päällystetyn, kokoonpuristetun tabletin valmist amiseksi lääkkeiden suun kautta tapahtuvaa antamista varten.
DE69022876D1 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
NL7610367A (nl) Aerosolafgeeforgaan voor het afgeven van uniforme doseringen van een fijnverdeeld medicament.
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
ES388698A1 (es) Procedimiento para la preparacion de pequenas bolitas medi-camentosas para administracion oral con un revestimiento re-tardador de la liberacion de sustancia activa.
JPS6360924A (ja) 徐放性口腔内用製剤
SE402709B (sv) Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav
IL41784A0 (en) Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them
BE745334A (fr) N-(2-(nitroimidazolyl) ethyl) imides, composes apparentes, leurprocede de preparation et medicaments notamment antiprotozoaires et anthelmintiques, les renfermant
FR2328466A1 (fr) Nouvelles 4-aminopyrazoles substituees, procede pour leur preparation et medicaments contenant ces composes
ATE77052T1 (de) Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte.
GB1385285A (en) Pharmaceutical capsule wall materials
US2963402A (en) Sustained release medicament
ES2060708T3 (es) Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.
DE2903778C2 (de) Verwendung von Hydroxypropylmethylcellulose zum Überziehen von den pharmazeutischen Wirkstoff in der Hülle enthaltenden Weichgelatine-Buccalkapseln
BE785378A (fr) Benzoyl-urees, leur preparation et medicament contenant ces substances
GB800973A (en) Improvements in or relating to pills or tablets
US2333283A (en) Administration capsule